Adamis Pharmaceuticals Corp reports results for the quarter ended in March - Earnings Summary

DMK Pharmaceuticals

17/05/2022 24:09

* Adamis Pharmaceuticals Corp  ADMP.OQ  reported a quarterly
adjusted loss of 7 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 3 cents per share.
    * Revenue fell 71.9% to $1.15 million from a year ago. 
    * Adamis Pharmaceuticals Corp's reported EPS for the quarter
was a
loss of 7 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Adamis Pharmaceuticals Corp shares had fallen by 32.6%
this
quarter and lost 36.4% so far this year.
    * The company reported a quarterly loss of $10.35 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 11:09 p.m.  ​All
figures in US dollars unless otherwise stated